Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 16OTHER 7NETWORK 1INDIV 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Colorectal Neoplasms 1Adenocarcinoma 1

Interventions

Tacrolimus 2Pyridostigmine Bromide 2Prednisone 2sargramostim 1pembrolizumab 1Watchful Waiting 1Steroids 1Mycophenolic Acid 1Methylprednisolone 1Methotrexate 1Ipilimumab 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Cyclosporine 1Cyclophosphamide 1Biological Products 1Azathioprine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDIV × Observational × Ipilimumab × Clear all
NCT03695835 2020-07-22

NIRPA

Gary Onik MD

Completed
27 enrolled
GastrointestinalGenitourinaryThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡